| Table 1. Description of the interventions by treatment group of the included studies. | ||||||
| Comparison | Study | Intervention group | Control group | Outcomes | ||
|---|---|---|---|---|---|---|
| Protocol | Type of ET | Protocol | Type of ET | |||
| GnRH protocol before COS and fresh ET | Ultralong GnRHa protocol | Long GnRHa protocol | ||||
|
|
Triptoreline acetate 3.75mg monthly for 3 months before COS. Cos started 30-45 days after the last GnSRHa injection | Fresh | Triptoreline acetate 0.1mg daily in the mid-luteal phase for 10 days followed by 0.05mg daily until de day of HCG injection. COS was started 10 days after the first GnRHa injection | Fresh | Clinical pregnancy rate, implantation rate, Miscarriage rate, Live birth rate | |
|
|
Triptoreline acetate 3.75mg monthly. Dose repeated up to 3 months if AP uterine dimameter was ≥ 70mm. Triptoreline acetate depot (1.0-1.8mg) or daily dose (0.05-0.1mg) was used for pituitary downregulation 28 days after the last monthly injection. COS was iniciated 14 days after the last injection for pituitary downregulation | Fresh | Triptoreline acetate 3.75mg monthly. Dose repeated up to 3 months if AP uterine dimameter was ≥ 70mm. Triptoreline acetate depot (1.0-1.8mg) or daily dose (0.05-0.1mg) was used for pituitary downregulation 28 days after the last monthly injection. COS was iniciated 14 days after the last injection for pituitary downregulation | Fresh | Clinical pregnancy, miscarriage and live birth rate | |
|
|
Triptoreline acetate 3.75 monthly for 2-4 months before COS. COS started 28 days after the last GnRHa injection | Fresh | Triptoreline acetate single dose of 0.93 - 1.87mg in the mid-luteal phase. COS was started 14 days after the GnRHa injection | Fresh | Biochemical pregnancy, implantation, miscarriage, clinical pregnancy, live birth rate | |
|
|
Triptoreline acetate 3.75mg monthly for 3 months. A 4th inhection was given if AP uterine diameter was ≥ 70mm. COS started 28 days after the last GnRHa injection | Fresh | Triptoreline acetate depot (1.0 + 1.8 mg) or daily dose (0.05 + 0.1mg) for pituitary downregulation. COS started 28 days after the last GnRHa injection | Fresh | Biochemical pregnancy, implantation, miscarriage, clinical pregnancy, live birth rate | |
|
|
Triptoreline acetate 3.75mg monthly. Dose repeated up to 6 months if AP uterine diameter was ≥ 70mm. | Fresh | Triptoreline acetate 3.75mg monthly. Dose repeated up to 6 months if AP uterine diameter was ≥ 70mm. | Fresh | Biochemical pregnancy, implantation, miscarriage, clinical pregnancy, live birth rate | |
| Ultralong GnRHa protocol | Antagonist protocol | |||||
|
|
Gosereline 3,75 mg monthly. Dose repeated up to 3 months if AP uterine diameter was ≥ 70mm. | Fresh | Daily dose (0.25mg) of GnRH-ant on iniciated based on a flexible protocol, once a folicle reached ≥ 12mm and until trigger day | Fresh | Clinical pregnancy, miscarriage rate | |
|
|
Triptoreline acetate 3.75mg monthly. Dose repeated up to 6 months if AP uterine diameter was ≥ 70mm. | Fresh | Daily dose (0.25mg) of GnRH-ant on iniciated based on a flexible protocol, once a folicle reached ≥ 12mm and until trigger day | Fresh | (see above) | |
| Long GnRHa protocol | Antagonist protocol | |||||
|
|
Triptoreline acetate (0.05-0.1mg) daily dose for 14 days | Fresh | Daily dose (0.25mg) of GnRH-ant on iniciated based on a flexible protocol, once a folicle reached ≥ 12mm and until trigger day | Fresh | (see above) | |
| Short GnRHa protocol | Antagonist protocol | |||||
|
|
Triptoreline acetate (0.05-0.1mg) daily dose on days 2-4 of the menstrual cycleuntil HCG trigger | Fresh | Daily dose (0.25mg) of GnRH-ant on iniciated based on a flexible protocol, once a folicle reached ≥ 12mm and until trigger day | Fresh | (see above) | |
| Pretreatment before FET | Pretreatment with GnRHa | No pretreatment | ||||
|
|
Leuproline acetate 3.75mg for 28 days followed by leuproline acetate 1.875 mg. 21 days after HRT was initiated. | Artificial cycle | No pretreatment before HRT | Artificial cycle | Implantation rate, clinical pregnancy | |
|
|
Triptoreline or leuprolide 3,75mg for 28 days. Patients with larger uterine volumes were administered additional injections. | Artificial cycle | No pretreatment before HRT | Artificial cycle | Implantation, clinical pregnancy, miscarriage and live birth rate | |
|
|
Triptoreline acetate 3,75mg monthly for 3 months before HRT. Some patients underwent FET < 3 months pretreatment | Artificial cycle | No pretreatment before HRT | Artificial cycle | Clinical pregnancy rate, live birth rate, miscarriage rate | |
*No data regarding the protocol for COS is provided the authors.